GenHealth.ai
Markets
Use Cases
Products
Company
Docs
Get a Demo
Automated Prior Authorization
with Generative AI. See how we support health plans and providers with prior auth.
Generative AI Healthcare Analytics
Use natural language to ask any question of your data: past, present, and future.
Search all medical codes
B97.35
Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere
ICD10CM code
Medical Policies and Guidelines for Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere
Related policies from health plans
CIGNA
Flow Cytometry - (0538)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
CIGNA
Nucleic Acid Pathogen Testing - (0530)
Similar Codes
ICD10CM codes
B97.35
- Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere
B97.34
- Human T-cell lymphotrophic virus, type II [HTLV-II] as the cause of diseases classified elsewhere
B97.33
- Human T-cell lymphotrophic virus, type I [HTLV-I] as the cause of diseases classified elsewhere
B97.31
- Lentivirus as the cause of diseases classified elsewhere
B20
- Human immunodeficiency virus [HIV] disease
B97.3
- Retrovirus as the cause of diseases classified elsewhere
B97.39
- Other retrovirus as the cause of diseases classified elsewhere
B97.0
- Adenovirus as the cause of diseases classified elsewhere
Z20.6
- Contact with and (suspected) exposure to human immunodeficiency virus [HIV]
B97.30
- Unspecified retrovirus as the cause of diseases classified elsewhere
HCPCS codes
G0432
- Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, scree
G0433
- Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 an
G0435
- Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening
G0475
- Hiv antigen/antibody, combination assay, screening
G0472
- Hepatitis c antibody screening, for individual at high risk and other covered indication(s)
J0850
- Injection, cytomegalovirus immune globulin intravenous (human), per vial
U0003
- Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavir
U0005
- Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavir
Q2039
- Influenza virus vaccine, not otherwise specified
J3485
- Injection, zidovudine, 10 mg
CPT4 codes
86702
- Antibody; HIV-2
87273
- Infectious agent antigen detection by immunofluorescent technique; Herpes simplex virus type 2
87806
- Infectious agent antigen detection by immunoassay with direct optical observation; HIV-1 antigen(s),
3510F
- Documentation that tuberculosis (TB) screening test performed and results interpreted (HIV) (IBD)
4293F
- Patient screened for high-risk sexual behavior (HIV)
87906
- Infectious agent genotype analysis by nucleic acid (DNA or RNA); HIV-1, other region (eg, integrase,
87390
- Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-l
87539
- Infectious agent detection by nucleic acid (DNA or RNA); HIV-2, quantification, includes reverse tra
86701
- Antibody; HIV-1
86689
- Antibody; HTLV or HIV antibody, confirmatory test (eg, Western Blot)